Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
2.
JMIR Cardio ; 5(2): e27347, 2021 Aug 31.
Article in English | MEDLINE | ID: mdl-34321194

ABSTRACT

BACKGROUND: The burden of time is often the primary reason why patients discontinue their treatment. Telemedicine may help patients adhere to treatment by offering convenience. OBJECTIVE: This study examined the efficacy and safety of telemedicine for the management of hypertension in Japan. METHODS: Patients with uncomplicated hypertension were recruited through web advertising between November 2015 and February 2017. They were then screened, stratified by office systolic blood pressure (SBP), and randomized into two groups: usual care (UC) and telemedicine. The telemedicine group used a 3G network-attached home blood pressure (BP) monitoring device, consulted hypertension specialists from an academic hospital through web-based video visits, and received prescription medication by mail for 1 year. The UC group used the same BP monitoring device but was managed using self-recorded BP readings, which included their diary entries and office BP taken in a community practice setting. RESULTS: Initial screening was completed by 99 patients, 54% of whom had untreated hypertension. Baseline BP was similar between the groups, but the weekly average SBP at the end of the 1-year study period was significantly lower in the telemedicine group (125, SD 9 mmHg vs 131, SD 12 mmHg, respectively; P=.02). SBP in the telemedicine group was 3.4 mmHg lower in the morning and 5.8 mmHg lower in the evening. The rate of SBP control (135 mmHg) was better in the telemedicine group (85.3% vs 70.0%; P=.01), and significant adverse events were not observed. CONCLUSIONS: We present evidence suggesting that antihypertensive therapy via home BP telemonitoring and web-based video visits achieve better BP control than conventional care and is a safe treatment alternative that warrants further investigation. TRIAL REGISTRATION: UMIN-CTR UMIN000025372; https://tinyurl.com/47ejkn4b.

3.
Hypertens Res ; 44(3): 276-285, 2021 03.
Article in English | MEDLINE | ID: mdl-33361825

ABSTRACT

Internet-based information and communication technology is altering our lives. Although medicine is traditionally conservative, it can benefit in many ways from adopting new technology and styles of care. Hypertension is a prime condition for the practical application of digital health management because it is prevalent and undercontrolled, and its primary index, home blood pressure, can be effectively telemonitored. Compared to other conditions that require laboratory measures or the use of drugs with frequent side effects, hypertension can be managed without actual office visits with sufficiently low risk. In this review of hypertension in Japan, we discuss the current and somewhat fragmented state of internet technology and the components and processes necessary for smooth, integrated, and multidisciplinary care in the future. Although further clinical trials are required to show the safety and efficacy of information and communication technology-based care for hypertension, the deployment of telemonitoring and telemedicine in daily practice should be expedited to solve the hypertension paradox. Challenges remain relating to cost, data integration, the redesigning of team-based care, and the improvement of user experience, but information and communication technology-based hypertension management is sure to become pivotal in improving public health.


Subject(s)
Hypertension , Internet , Technology , Telemedicine , Forecasting , Humans , Hypertension/therapy , Japan , Telemedicine/trends
4.
Nat Rev Nephrol ; 15(11): 693-712, 2019 11.
Article in English | MEDLINE | ID: mdl-31164719

ABSTRACT

The (pro)renin receptor ((P)RR) was first identified as a single-transmembrane receptor in human kidneys and initially attracted attention owing to its potential role as a regulator of the tissue renin-angiotensin system (RAS). Subsequent studies found that the (P)RR is widely distributed in organs throughout the body, including the kidneys, heart, brain, eyes, placenta and the immune system, and has multifaceted functions in vivo. The (P)RR has roles in various physiological processes, such as the cell cycle, autophagy, acid-base balance, energy metabolism, embryonic development, T cell homeostasis, water balance, blood pressure regulation, cardiac remodelling and maintenance of podocyte structure. These roles of the (P)RR are mediated by its effects on important biological systems and pathways including the tissue RAS, vacuolar H+-ATPase, Wnt, partitioning defective homologue (Par) and tyrosine phosphorylation. In addition, the (P)RR has been reported to contribute to the pathogenesis of diseases such as fibrosis, hypertension, pre-eclampsia, diabetic microangiopathy, acute kidney injury, cardiovascular disease, cancer and obesity. Current evidence suggests that the (P)RR has key roles in the normal development and maintenance of vital organs and that dysfunction of the (P)RR is associated with diseases that are characterized by a disruption of the homeostasis of physiological functions.


Subject(s)
Receptors, Cell Surface/physiology , Vacuolar Proton-Translocating ATPases/physiology , Brain/physiology , Brain/physiopathology , Eye/physiopathology , Female , Heart/physiology , Heart/physiopathology , Homeostasis/physiology , Humans , Immune System/physiology , Immune System/physiopathology , Kidney/physiology , Kidney/physiopathology , Ocular Physiological Phenomena , Placenta/physiology , Placenta/physiopathology , Pregnancy , Renin-Angiotensin System/physiology
5.
BMC Infect Dis ; 18(1): 363, 2018 08 02.
Article in English | MEDLINE | ID: mdl-30071825

ABSTRACT

BACKGROUND: Clostridium ramosum is a generally non-pathogenic enteric anaerobe, and Fournier's gangrene is a rare necrotizing soft tissue infection with male predisposition affecting the perineum and the genital area. We report, to our knowledge, the first case of Fournier's gangrene caused by C. ramosum in a female patient with multiple underlying conditions. CASE PRESENTATION: A 44-year-old woman with a 6-year history of insulin-dependent diabetes mellitus after total pancreatectomy and an 11-year history of central diabetes insipidus developed a pain in the genital area after a month of urinary catheter use. The lower abdominal pain worsened gradually over 2 weeks, and the pain, general fatigue, and loss of appetite prompted the patient's hospital admission. As she had severe edema in her pelvic and bilateral femoral areas, ceftriaxone was started empirically after collecting two sets of blood cultures. On hospital day 2, CT examination revealed the presence of necrotizing faciitis in the genital and pelvic areas, and the antibiotics were changed to a combination of meropenem, vancomycin, and clindamycin. Gram-positive cocci and gram-positive rods were isolated from blood cultures, which were finally identified as Streptococcus constellatus and C. ramosum using superoxide dismutase and 16S rDNA sequencing. An emergent surgery was performed on hospital day 2 to remove the affected tissue. Despite undergoing debridement and receiving combined antimicrobial chemotherapies, the patient's clinical improvement remained limited. The patient's condition continued to deteriorate, and she eventually died on hospital day 8. In the present case, the underlying diabetes mellitus, urinary incontinence due to central diabetes insipidus, undernutrition, and edema served as the predisposing conditions. CONCLUSIONS: C. ramosum is a potentially opportunistic pathogen among immunosuppressed persons and a rare cause of necrotizing fasciitis.


Subject(s)
Clostridium Infections/complications , Clostridium , Diabetes Insipidus, Neurogenic/complications , Diabetes Mellitus, Type 1/complications , Fournier Gangrene/microbiology , Adult , Fatal Outcome , Female , Humans
6.
Blood Press ; 27(2): 99-105, 2018 04.
Article in English | MEDLINE | ID: mdl-29172715

ABSTRACT

PURPOSE: Although self-measurement of home blood pressure (HBP) is common in Japan and HBP telemonitoring via the Internet is possible, whether telemonitoring improves HBP control better than conventional practice remains unclear. Furthermore, hypertension care with online communication using telemonitored HBP is feasible, whereas the efficacy and safety of such telemedicine have not been established. We aim to compare traditional care, care with office visits using HBP telemonitoring, and antihypertensive telemedicine based on HBP telemonitoring. METHODS AND DESIGN: In total, 444 patients with uncontrolled hypertension will be recruited and randomly assigned to three groups: (1) control: usual care with office visits and HBP self-report, (2) telemonitoring: weekly assessment of transmitted HBP by physicians and treatment adjustment upon office visits, or (3) telemedicine: online communication instead of office visits to adjust medication using telemonitored HBP. Primary outcome is the time to control of HBP, and secondary outcomes include achieved HBP levels, adherence, treatment intensity, adverse events, patient satisfaction and cost-effectiveness. DISCUSSION: Hypertension care with telemonitoring and telemedicine are expected to require shorter time to achieve HBP control compared to usual care. Combining HBP telemonitoring with telemedicine may lower the hurdles for starting and persisting to hypertension treatment and eventually reduce cardiovascular events.


Subject(s)
Blood Pressure Monitoring, Ambulatory/methods , Hypertension/physiopathology , Telemedicine/methods , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult
7.
Nutrients ; 9(9)2017 Aug 29.
Article in English | MEDLINE | ID: mdl-28850062

ABSTRACT

The Na/K ratio is considered to be a useful index, the monitoring of which allows an effective Na reduction and K increase, because practical methods (self-monitoring devices and reliable individual estimates from spot urine) are available for assessing these levels in individuals. An intervention trial for lowering the Na/K ratio has demonstrated that a reduction of the Na/K ratio mainly involved Na reduction, with only a small change in K. The present study aimed to clarify the relationship between dietary Na intake and the urinary Na/K molar ratio, using standardized low- and high-salt diets, with an equal dietary K intake, to determine the corresponding Na/K ratio. Fourteen healthy young adult volunteers ingested low-salt (3 g salt per day) and high-salt (20 g salt per day) meals for seven days each. Using a portable urinary Na/K meter, participants measured their spot urine at each voiding, and 24-h urine was collected on the last day of each diet period. On the last day of the unrestricted, low-salt, and high-salt diet periods, the group averages of the 24-h urine Na/K ratio were 4.2, 1.0, and 6.9, while the group averages of the daily mean spot urine Na/K ratio were 4.2, 1.1, and 6.6, respectively. The urinary Na/K ratio tracked changes in dietary salt intake, and reached a plateau approximately three days after each change in diet. Frequent monitoring of the spot urine Na/K ratio may help individuals adhere to an appropriate dietary Na intake.


Subject(s)
Meals , Potassium/urine , Sodium Chloride/administration & dosage , Sodium/urine , Adult , Asian People , Female , Humans , Male , Potassium, Dietary , Reproducibility of Results , Sodium Chloride, Dietary , Urinalysis/standards , Young Adult
9.
Clin Exp Nephrol ; 19(4): 585-90, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25410661

ABSTRACT

BACKGROUND: Na(+)/Ca(2+) exchanger 1 (NCX1) controls intracellular Ca(2+) concentration in various cell types. In the kidney, NCX1 is expressed mainly in the distal tubular basolateral membrane as well as in vascular smooth muscle. Tubular NCX1 is involved in Ca(2+) reabsorption, and NCX1 in renal arterioles may control intraglomerular pressure. However, the functions of renal NCX1 have not been studied in vivo. Therefore, this study examined the effects of renal NCX1 blockade on water and solute metabolism, renal function and blood pressure in rats. METHODS: Wistar-Kyoto rats were uninephrectomized, and an osmotic mini pump was implanted to infuse the remnant kidney cortex with a specific NCX1 inhibitor, SEA0400 (SEA), or vehicle for 7 days. RESULTS: Serum Ca(2+) concentration and urinary Ca(2+) excretion were similar between the vehicle- and SEA-treated groups. However, serum phosphate was significantly decreased by 8 % in the SEA group, with similar urinary phosphate excretion between the two groups. Systolic blood pressure was higher in the SEA group (117 ± 3 vs. 126 ± 1 mmHg, n = 9-11), with a 1.6-fold increase in plasma aldosterone concentration. However, SEA significantly reduced urinary protein excretion and the glomerular sectional area by 16 and 8 %, respectively. Similar experiment in spontaneously hypertensive rats produced different results. CONCLUSION: Renal SEA treatment reduced serum phosphate concentration, urinary protein and glomerular size with higher systemic blood pressure compared to control Wistar-Kyoto rats. Further study on renal NCX1 may be beneficial in delineating the pathophysiology of glomerular pressure control and calcium/phosphate regulations.


Subject(s)
Aniline Compounds/pharmacology , Calcium/metabolism , Kidney/metabolism , Phenyl Ethers/pharmacology , Sodium-Calcium Exchanger/metabolism , Water-Electrolyte Balance/drug effects , Animals , Blood Pressure/drug effects , Kidney/drug effects , Male , Rats, Inbred WKY , Renal Circulation/drug effects , Sodium-Calcium Exchanger/antagonists & inhibitors
10.
PLoS One ; 9(9): e105835, 2014.
Article in English | MEDLINE | ID: mdl-25188493

ABSTRACT

Gamma-aminobutyric acid (GABA) is an important neurotransmitter, but recent reports have revealed the expression of GABAergic components in peripheral, non-neural tissues. GABA administration induces natriuresis and lowers blood pressure, suggesting renal GABA targets. However, systematic evaluation of renal GABAergic components has not been reported. In this study, kidney cortices of Wistar-Kyoto rats (WKY) were used to assay for messenger RNAs of GABA-related molecules using RT-PCR. In WKY kidney cortex, GABAA receptor subunits, α1, ß3, δ, ε and π, in addition to both types of GABAB receptors, R1 and R2, and GABAC receptor ρ1 and ρ2 subunit mRNAs were detected. Kidney cortex also expressed mRNAs of glutamate decarboxylase (GAD) 65, GAD67, 4-aminobutyrate aminotransferase and GABA transporter, GAT2. Western blot and/or immunohistochemistry were performed for those molecules detected by RT-PCR. By immunofluorescent observation, co-staining of α1, ß3, and π subunits was observed mainly on the apical side of cortical tubules, and immunoblot of kidney protein precipitated with π subunit antibody revealed α1 and ß3 subunit co-assembly. This is the first report of GABAA receptor π subunit in the kidney. In summary, unique set of GABA receptor subunits and subtypes were found in rat kidney cortex. As GABA producing enzymes, transporters and degrading enzyme were also detected, a possible existence of local renal GABAergic system with an autocrine/paracrine mechanism is suggested.


Subject(s)
GABA Plasma Membrane Transport Proteins/genetics , Kidney Cortex/metabolism , Receptors, GABA-A/genetics , gamma-Aminobutyric Acid/biosynthesis , 4-Aminobutyrate Transaminase/genetics , 4-Aminobutyrate Transaminase/metabolism , Adult , Animals , Female , GABA Plasma Membrane Transport Proteins/metabolism , Gene Expression , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Humans , Hypertension/genetics , Hypertension/metabolism , Immunohistochemistry , Male , Protein Subunits , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptors, GABA-A/classification , Receptors, GABA-A/metabolism
11.
Diagn Pathol ; 8: 203, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24325735

ABSTRACT

Most tumor markers have low detection rates for curable stages of cancer and are therefore not satisfactory for use in a healthy population. A new cancer risk calculation method, AminoIndex Cancer Screening (AICS), uses multiple plasma amino acid concentrations to calculate the risks for several cancers simultaneously and is suggested to have a high detection rate for early-stage cancers and a low false-positive rate for adenomas. Here, we describe a male patient with a family history of colorectal cancer who underwent AICS. He was judged as Rank C for colorectal cancer, which reportedly has a specificity of 95%, a sensitivity of 41%, and an estimated positive predictive value of 0.67%. He underwent colonoscopy for a secondary screening, which revealed a 10-mm adenoma-like lesion in the ascending colon, with a biopsy report of partial carcinoma. The tumor was endoscopically removed and diagnosed as carcinoma in situ (carcinoma in adenoma). This early detection method allowed complete resection of the carcinoma, and the patient is in remission. This is the first case in which a curable cancer was detected using AICS. With its high detection rate for early-stage cancers and its ease of use, this tool, which recently became available in Japan, may be beneficial for simultaneous screening of the general population for multiple cancers. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2145080259887842.


Subject(s)
Adenoma/diagnosis , Amino Acids/blood , Biomarkers, Tumor/blood , Carcinoma in Situ/diagnosis , Colonic Neoplasms/diagnosis , Early Detection of Cancer/methods , Proteomics , Adenoma/blood , Adenoma/pathology , Adenoma/surgery , Biopsy , Carcinoma in Situ/blood , Carcinoma in Situ/pathology , Carcinoma in Situ/surgery , Colonic Neoplasms/blood , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Colonoscopy , Humans , Male , Middle Aged , Neoplasm Staging , Predictive Value of Tests , Remission Induction , Treatment Outcome
12.
BMC Nephrol ; 13: 160, 2012 Dec 02.
Article in English | MEDLINE | ID: mdl-23199000

ABSTRACT

BACKGROUND: Urinary Ca2+ excretion increases with dietary NaCl. NaCl-induced calciuria may be associated with hypertension, urinary stone formation and osteoporosis, but its mechanism and long-term effects are not fully understood. This study examined alterations in the expressions of renal Ca2+ transporters, channels and claudins upon salt loading to better understand the mechanism of salt-induced urinary Ca2+ loss. METHODS: Eight-week old Wistar-Kyoto rats were fed either 0.3% or 8% NaCl diet for 8 weeks. Renal cortical expressions of Na+/Ca2+ exchanger 1 (NCX1), Ca2+ pump (PCMA1b), Ca2+ channel (TRPV5), calbindin-D28k, and claudins (CLDN-2, -7, -8, -16 and -19) were analyzed by quantitative PCR, western blot and/or immunohistochemistry. RESULTS: Fractional excretion of Ca2+ increased 6.0 fold with high-salt diet. Renal cortical claudin-2 protein decreased by approximately 20% with decreased immunological staining on tissue sections. Claudin-16 and -19 expressions were not altered. Renal cortical TRPV5, calbindin-D28k and NCX1 expressions increased 1.6, 1.5 and 1.2 fold, respectively. CONCLUSIONS: Chronic high-salt diet decreased claudin-2 protein and increased renal TRPV5, calbindin-D28k, and NCX1. Salt loading is known to reduce the proximal tubular reabsorption of both Na+ and Ca2+. The reduction in claudin-2 protein expression may be partly responsible for the reduced Ca2+ reabsorption in this segment. The concerted upregulation of more distal Ca2+-transporting molecules may be a physiological response to curtail the loss of Ca2+, although the magnitude of compensation does not seem adequate to bring the urinary Ca2+ excretion down to that of the normal-diet group.


Subject(s)
Calcium Channels/biosynthesis , Claudin-2/biosynthesis , Kidney Tubules/metabolism , S100 Calcium Binding Protein G/biosynthesis , Sodium Chloride, Dietary/administration & dosage , Sodium-Calcium Exchanger/biosynthesis , TRPV Cation Channels/biosynthesis , Animals , Calbindin 1 , Calbindins , Calcium/urine , Gene Expression Regulation , Rats , Rats, Inbred WKY , Sodium Chloride, Dietary/adverse effects
13.
Am J Physiol Renal Physiol ; 296(5): F1052-60, 2009 May.
Article in English | MEDLINE | ID: mdl-19261744

ABSTRACT

It has been reported that mechanical strain activates extracellular signal-regulated protein kinases (ERK) without the involvement of angiotensin II (Ang II) in cardiomyocytes. We examined the effects of mechanical strain on ERK phosphorylation levels in the absence of Ang II using rat mesangial cells. The ratio of phosphorylated ERK (p-ERK) to total ERK expression was increased by cyclic mechanical strain in a time- and elongation strength-dependent manner. With olmesartan [Ang II type 1 receptor (AT1R) antagonist] pretreatment, p-ERK plateau levels decreased in a dose-dependent manner (EC(50) = 1.3 x 10(-8) M, maximal inhibition 50.6 +/- 11.0% at 10(-5) M); a similar effect was observed with RNA interference against Ang II type 1A receptor (AT(1A)R) and Tempol, a superoxide dismutase mimetic. In addition to the inhibition of p-ERK levels, olmesartan blocked the increase in cell surface and phosphorylated p47(phox) induced by mechanical strain and also lowered the mRNA expression levels of NADPH oxidase subunits. These results demonstrate that mechanical strain stimulates AT1R to phosphorylate ERK in mesangial cells in the absence of Ang II. This mechanotransduction mechanism is involved in the oxidative stress caused by NADPH oxidase and is blocked by olmesartan. The inverse agonistic activity of this AT1R blocker may be useful for the prevention of mesangial proliferation and renal damage caused by mechanical strain/oxidative stress regardless of circulating or tissue Ang II levels.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Imidazoles/pharmacology , Mesangial Cells/drug effects , Mesangial Cells/enzymology , NADH, NADPH Oxidoreductases/metabolism , Tetrazoles/pharmacology , Angiotensin II/pharmacology , Animals , Autocrine Communication/drug effects , Autocrine Communication/physiology , Cells, Cultured , Chelating Agents/pharmacology , Cytochalasin D/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Gene Expression/drug effects , Gene Expression/physiology , Hypertension, Renal/drug therapy , Hypertension, Renal/metabolism , Hypertension, Renal/physiopathology , Male , Mesangial Cells/cytology , MicroRNAs/pharmacology , NADPH Oxidase 1 , Nucleic Acid Synthesis Inhibitors/pharmacology , Oxidative Stress/physiology , Paracrine Communication/drug effects , Paracrine Communication/physiology , Phosphorylation/physiology , Rats , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1/genetics , Receptor, Angiotensin, Type 1/metabolism , Stress, Mechanical , Vasoconstrictor Agents/pharmacology
14.
Biol Pharm Bull ; 32(3): 325-31, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19252272

ABSTRACT

Here we reviewed our recent work on the chronic effects of nicotine on the Na+ -Ca2+ exchanger (NCX) gene and protein expressions in various organs of rats treated with nicotine in the drinking water for 4-12 weeks. Microarray analysis and reverse transcriptase-polymerase chain reaction (RT-PCR) did not detect significant changes in NCX mRNA expression in cerebral cortex, hippocampus, heart and skeletal muscle. However, NCX1 protein was up-regulated by nicotine in cerebral cortex and hippocampus, but was down-regulated in the heart. NCX2 protein was up-regulated by nicotine in hippocampus. We suggest that although mRNA change was insignificant, NCX protein expression was altered by chronic nicotine administration in brain and heart in rats. We also reviewed our work on modulators of NCX gene expression and function in cardiac myocytes.


Subject(s)
Nicotine/pharmacology , Sodium-Calcium Exchanger/biosynthesis , Adrenal Medulla/drug effects , Adrenal Medulla/metabolism , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Chromaffin Cells/drug effects , Chromaffin Cells/metabolism , Dose-Response Relationship, Drug , Gene Expression Profiling , Gene Expression Regulation , Hippocampus/drug effects , Hippocampus/metabolism , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Myocardium/metabolism , Oligonucleotide Array Sequence Analysis , Organ Specificity , RNA, Messenger/biosynthesis , Rats , Sodium-Calcium Exchanger/genetics
15.
Hypertens Res ; 28(11): 871-8, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16555575

ABSTRACT

Hypertension is a major risk factor for atherosclerotic cardiovascular disease. Selectins, cell-surface adhesion molecules involved in leukocyte rolling and attachment to the vascular endothelium, play a role in the initiation of atherosclerosis. We investigated whether or not serum levels of soluble adhesion molecules are elevated in patients with essential hypertension (EH) and examined whether antihypertensive therapy lowers such levels. Twenty-one patients who had untreated mild to moderate EH without diabetes mellitus, hyperlipidemia, or obesity were recruited at a clinic for hypertensive patients. Blood pressure was measured, and the serum levels of soluble E-selectin, P-selectin, L-selectin, intercellular adhesion molecule 1 (ICAM-1), and vascular-cell adhesion molecule 1 (VCAM-1) were determined by enzyme-linked immunosorbent assays before and after 12, 24, and 53 weeks of antihypertensive treatment with benidipine, a long-acting calcium channel blocker, given at a dose of 6 mg/day for 53 weeks. As a control, 21 age- and sex-matched patients without hypertension were studied. Serum E- and P-selectin levels were significantly higher in the subjects with EH than in the controls (p < 0.01). There were no differences in serum levels of soluble L-selectin, VCAM-1, or ICAM-1 levels between the patients with EH and the controls. Treatment with benidipine decreased the elevated blood pressure over a 53-week study period (mean blood pressure: 119.8 +/- 6.5 mmHg at baseline, 101.0 +/- 5.9 mmHg at 12 weeks, 98.6 +/- 7.3 mmHg at 24 weeks, and 93.9 +/- 5.5 mmHg at 53 weeks). Serum levels of soluble E- and P-selectin decreased after the initiation of benidipine treatment and correlated with diastolic blood pressure. Serum levels of soluble L-selectin, VCAM-1, and ICAM-1 did not change significantly during the period of benidipine treatment. Benidipine treatment reduced the content of P-selectin in the platelets from patients with EH, as determined by Western blot analysis. In conclusion, decreased blood pressure may reduce the rate of progression of atherosclerosis by affecting the expression of E- and P-selectin in the endothelium, the platelets, or both. Benidipine may be protective against vascular damage in people with hypertension, not only by lowering blood pressure, but also by inhibiting the expression of selectins.


Subject(s)
Calcium Channel Blockers/pharmacology , Dihydropyridines/pharmacology , E-Selectin/drug effects , Hypertension/drug therapy , P-Selectin/drug effects , Blotting, Western , Calcium Channel Blockers/therapeutic use , Case-Control Studies , Cell Adhesion Molecules/blood , Cell Adhesion Molecules/drug effects , Dihydropyridines/therapeutic use , E-Selectin/blood , Female , Humans , Hypertension/blood , Male , Middle Aged , P-Selectin/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...